Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cornelia Hagmann

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
IEEE Transactions on Medical Imaging|May 15, 2025
CLIF-Net: Intersection-guided Cross-view Fusion Network for Infection Detection from Cranial UltrasoundMingzhao Yu, Mallory R Peterson, Kathy Burgoine, et al.
Medrxiv : the Preprint Server for Health Sciences|August 8, 2025
CLIF-Net: Intersection-guided Cross-view Fusion Network for Infection Detection from Cranial UltrasoundMingzhao Yu, Mallory R Peterson, Kathy Burgoine, et al.
Swiss Medical Weekly|June 25, 2020
Swiss newborn screening for severe T and B cell deficiency with a combined TREC/KREC assay - management recommendationsJohannes Trück, Seraina Prader, Giancarlo Natalucci, et al.
Pediatric Research|November 17, 2015
Brain injury in the international multicenter randomized SafeBoosC phase II feasibility trial: cranial ultrasound and magnetic resonance imaging assessmentsAnne M Plomgaard, Cornelia Hagmann, Thomas Alderliesten, et al.
Pediatric Surgery International|January 12, 2021
Fetal surgery for spina bifida in Zurich: results from 150 casesUeli Moehrlen, Nicole Ochsenbein, Ladina Vonzun, et al.
Cerebral Cortex (New York, N.Y. : 1991)|November 22, 2023
Thalamic connectivity topography in newborns with spina bifida: association with neurological functional level but not developmental outcome at 2 yearsHui Ji, Kelly Payette, Anna Speckert, et al.
Plos One|March 23, 2017
Early biomarkers of brain injury and cerebral hypo- and hyperoxia in the SafeBoosC II trialAnne M Plomgaard, Thomas Alderliesten, Topun Austin, et al.
Pediatric Research|December 19, 2015
The SafeBoosC II randomized trial: treatment guided by near-infrared spectroscopy reduces cerebral hypoxia without changing early biomarkers of brain injuryAnne M Plomgaard, Wim van Oeveren, Tue H Petersen, et al.
Eclinicalmedicine|February 12, 2019
Early Childhood Outcomes After Neonatal Encephalopathy in Uganda: A Cohort StudyCally J Tann, Emily L Webb, Rachel Lassman, et al.
Neonatology|August 8, 2013
The SafeBoosC phase II randomised clinical trial: a treatment guideline for targeted near-infrared-derived cerebral tissue oxygenation versus standard treatment in extremely preterm infantsAdelina Pellicer, Gorm Greisen, Manon Benders, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
IEEE Transactions on Medical Imaging|May 15, 2025
CLIF-Net: Intersection-guided Cross-view Fusion Network for Infection Detection from Cranial UltrasoundMingzhao Yu, Mallory R Peterson, Kathy Burgoine, et al.
Medrxiv : the Preprint Server for Health Sciences|August 8, 2025
CLIF-Net: Intersection-guided Cross-view Fusion Network for Infection Detection from Cranial UltrasoundMingzhao Yu, Mallory R Peterson, Kathy Burgoine, et al.
Swiss Medical Weekly|June 25, 2020
Swiss newborn screening for severe T and B cell deficiency with a combined TREC/KREC assay - management recommendationsJohannes Trück, Seraina Prader, Giancarlo Natalucci, et al.
Pediatric Research|November 17, 2015
Brain injury in the international multicenter randomized SafeBoosC phase II feasibility trial: cranial ultrasound and magnetic resonance imaging assessmentsAnne M Plomgaard, Cornelia Hagmann, Thomas Alderliesten, et al.
Pediatric Surgery International|January 12, 2021
Fetal surgery for spina bifida in Zurich: results from 150 casesUeli Moehrlen, Nicole Ochsenbein, Ladina Vonzun, et al.
Cerebral Cortex (New York, N.Y. : 1991)|November 22, 2023
Thalamic connectivity topography in newborns with spina bifida: association with neurological functional level but not developmental outcome at 2 yearsHui Ji, Kelly Payette, Anna Speckert, et al.
Plos One|March 23, 2017
Early biomarkers of brain injury and cerebral hypo- and hyperoxia in the SafeBoosC II trialAnne M Plomgaard, Thomas Alderliesten, Topun Austin, et al.
Pediatric Research|December 19, 2015
The SafeBoosC II randomized trial: treatment guided by near-infrared spectroscopy reduces cerebral hypoxia without changing early biomarkers of brain injuryAnne M Plomgaard, Wim van Oeveren, Tue H Petersen, et al.
Eclinicalmedicine|February 12, 2019
Early Childhood Outcomes After Neonatal Encephalopathy in Uganda: A Cohort StudyCally J Tann, Emily L Webb, Rachel Lassman, et al.
Neonatology|August 8, 2013
The SafeBoosC phase II randomised clinical trial: a treatment guideline for targeted near-infrared-derived cerebral tissue oxygenation versus standard treatment in extremely preterm infantsAdelina Pellicer, Gorm Greisen, Manon Benders, et al.
Pageof 9